Resverlogix Corp. (TSX:RVX)
0.0750
0.00 (0.00%)
Nov 20, 2026, 9:30 AM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 25.82 million as of November 20, 2026. It is the 37,150th most valuable company in the world and the 1,129th biggest in Canada. Its market cap has decreased by 14.42% in one year.
Market Cap
25.82M
Enterprise Value
135.88M
Revenue
n/a
Global Rank
Country Rank
#1,129 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 25.82M, an increase of 12.56%. That is a compound annual growth rate of 0.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 25.82M | -10.20% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedMira | 38.60M |
| BriaCell Therapeutics | 38.42M |
| Sernova Biotherapeutics | 33.99M |
| ME Therapeutics Holdings | 31.91M |
| Sona Nanotech | 31.31M |
| Telescope Innovations | 20.21M |
| Medicenna Therapeutics | 18.92M |
| Devonian Health Group | 18.77M |